Pfizer Recalls Nurtec ODT Migraine Drugs Over Lack of Child-Proof Packaging
2023年3月16日 - 11:17PM
Dow Jones News
By Will Feuer
Pfizer Inc. is recalling about 4.2 million units of Nurtec ODT
prescription drugs because the packaging isn't child resistant.
The packaging of the more than 4 million units of the
prescription migraine medication failed to meet the requirements of
the Poison Prevention Packaging Act, the U.S. Consumer Product
Safety Commission said.
The recall applies to 75 milligram Nurtec ODT orally
disintegrating tablets that are sold in cartons containing one
blister card of 8 tablets. According to the CPSC, the tablets are
in a non-child resistant blister card.
The recall applies to all units with an expiration date through
June 2026, the CPSC said.
Write to Will Feuer at Will.Feuer@wsj.com
(END) Dow Jones Newswires
March 16, 2023 10:02 ET (14:02 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.
Pfizer (NYSE:PFE)
過去 株価チャート
から 5 2023 まで 6 2023
Pfizer (NYSE:PFE)
過去 株価チャート
から 6 2022 まで 6 2023
